Brandon Petrone
Orthopedic Surgery · Plainview, NYNPI 1801328406
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.5%), grants and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Stryker at 48.1% of the total. Reporting peaked in 2022 at $2,531 and has fallen 58.4% since, to $1,054 in 2025.
Across 33 payments — averaging $196.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Medtronic$2K
- Medical Device Business Services, Inc.$1K
- Orthofix Medical, Inc.$205
- Cerapedics Inc.$54
- Merz Pharmaceuticals, LLC$18
What the payments were for
- Grants$1,50023%
- Travel & lodging$3,54455%
- Food & beverage$1,45422%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $3,128 |
| Medtronic | 9 | $2,064 |
| Medical Device Business Services, Inc. | 5 | $1,029 |
| Orthofix Medical, Inc. | 2 | $205 |
| Cerapedics Inc. | 2 | $54 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE BONE GRAFT$1,500
- N/A$1,433
- Velys$963
- CASCADIA INTERBODY SYSTEM$868
- EVEREST SPINAL SYSTEM$592
- Spinal-Stim$340
- CD HORIZON SPINAL SYSTEM$163
- MAZOR X SYSTEM$154
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$144
How this compares
$6,498 in reported general payments places this provider in the 75th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 140 | $4,962 |
| Gabapentin | 278 | $1,928 |
| Pregabalin | 38 | $1,290 |
| Lidocaine | 18 | $960 |
| Methylprednisolone | 130 | $733 |
| Diclofenac Sodium | 47 | $457 |
| Meloxicam | 100 | $234 |
| Methocarbamol | 23 | $128 |
| Naproxen | 21 | $110 |
| Tramadol Hcl | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Plainview
- Evan GreenPlainview$3K
- Baron LonnerNew York$2.1M
- Jan KoenigRockville Centre$1.4M
- Lon WeinerNew York$622K
- Andrew CappuccinoLockport$581K
- Douglas PadgettUniondale$407K
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
- Jason McKeanBrooklyn$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.